Discover How Corning Products Help MEARY Center Paris Advance Personalized Medicine

An interview with Dr. Guillaume Churlaud

Dr. Guillaume Churlaud and his team produce cell and gene therapies, such as mesenchymal stromal cells, Treg lymphocytes, CAR-T cells, NK cells, and other ATMPs. All ATMPs produced in the MEARY Center are for phase 1 and 2 clinical trials. They produce new cells and new gene therapy drugs to treat patients suffering from autoimmune, hematological, and cardiac diseases, and so much more.

MEARY Center is the Paris University Hospitals Consortium’s core facility for cell and gene therapy. It is dedicated to the manufacturing of Advanced Therapy Medicinal Products (ATMPs) for the 39 leading university hospitals belonging to AP-HP (www.centremeary.aphp.fr). Located at the heart of Paris within Saint-Louis Hospital, it is embedded in an ecosystem connecting patients, research, and therapeutic innovation. The MEARY Center is accessible to diverse collaborators such as academic, biotech, and pharma companies.